Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.40 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.38 |
| ▸ | PTPRC | P08575 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20047171 | 0.92 | KMT2A (0.50) | KMT2AMEN1L3MBTL1TP53ESR2 | |
| SCHEMBL20047028 | 0.86 | SMN1; SMN2 (0.47) | KMT2AMEN1L3MBTL1ESR2LMNA | |
| SCHEMBL20047032 | 0.84 | KMT2A (0.47) | KMT2AMEN1L3MBTL1TP53ESR2 | |
| SCHEMBL20047022 | 0.80 | MEN1 (0.43) | KMT2AMEN1L3MBTL1ESR2LMNA | |
| SCHEMBL20047024 | 0.80 | CHRM5 (0.41) | KMT2AMEN1L3MBTL1ESR2LMNA | |
| SCHEMBL20047027 | 0.79 | PKM (0.51) | KMT2AMEN1L3MBTL1ESR2LMNA | |
| SCHEMBL20047020 | 0.79 | MEN1 (0.40) | KMT2AMEN1L3MBTL1ESR2LMNA | |
| SCHEMBL20047019 | 0.78 | MEN1 (0.40) | KMT2AMEN1L3MBTL1TP53ESR2 | |
| SCHEMBL20047023 | 0.78 | AKR1C3 (0.49) | KMT2AMEN1L3MBTL1AKR1C3AKR1C1 | |
| SCHEMBL20047029 | 0.78 | CYP11B1 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017223514-A9 | LXR INVERSE AGONISTS FOR TREATMENT OF CANCER | SAINT LOUIS UNIVERSITY (US) | 2018-04-12 | — | — | WO | disclosed |